Brrr! As temperatures drop, you might think all you need to worry about is bundling up, but did you know you could actually ...

Jan. 27, 2025 (GLOBE NEWSWIRE) -- Allakos Inc. (Company) (Nasdaq: ALLK), today announced topline results from its phase 1 clinical trial of AK006 in chronic spontaneous urticaria (CSU).

The Impact of Targeted Therapy The treatment of chronic urticaria (CU), a condition highlighted by constant itching and hives, is undergoing a notable breakthrough, which majorly pertains to the ...

Contact urticaria develops at the site(s) of contact of an urticant, and the diagnosis is usually self-evident. It can be divided into an allergic subgroup caused by an IgE-allergen interaction ...

Management of urticaria de pends on its cause. Aggravating factors should be identified from the history, and triggering stimuli for physical urticaria avoided. Simple cooling lotions, as 0.5% to ...